Baby Safety / Compounds / Acetaminophen (APAP)

Is Acetaminophen (APAP) safe for babies and kids?

Moderate risk for kids

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Acetaminophen (APAP) poses heightened risk.

What is acetaminophen (apap)?

The IUPAC name is N-(4-hydroxyphenyl)acetamide.

Also known as: N-(4-hydroxyphenyl)acetamide, acetaminophen, Paracetamol, 4-Acetamidophenol.

IUPAC name
N-(4-hydroxyphenyl)acetamide
CAS number
103-90-2
Molecular formula
C8H9NO2
Molecular weight
151.16 g/mol
SMILES
CC(=O)NC1=CC=C(C=C1)O
PubChem CID
1983

Risk for babies

Moderate risk

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Acetaminophen (APAP) poses heightened risk.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Elevated risk

Acetaminophen (APAP) poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

8 regulatory and scientific bodies have classified Acetaminophen (APAP). The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA—OTC analgesic/antipyreticFDA-approved; safe and effective at recommended doses (≤4 g/day)
EPA CTX / IARC—Group 3 - Not classifiable as to its carcinogenicity to humans
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 0 positive / 8 negative reports)
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 0 positive / 8 negative reports)
EPA CTX / Skin-Eye—Skin Sensitization: SkinSens1 (score: high)
EPA CTX / Skin-Eye—skin irritation: in vivo: Moderate or Mild Irritation (score: moderate)
FDA2024OTC_monographMax 4000 mg/day adult.
WHO2024essential_medicineWHO Essential Medicines List

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter acetaminophen (apap)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Acetaminophen (APAP):

  • Bio-based polymer alternatives where available
    Trade-offs: Performance limitations. End-of-life complexity.
    Relative cost: 2-5× conventional
  • Ibuprofen
    Relative cost: 1.2-2×
  • Naproxen
    Relative cost: 1.2-2×
  • Non-pharmacological pain management
    Relative cost: 1.2-2×

Frequently asked questions

Is acetaminophen (apap) safe for kids?

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Acetaminophen (APAP) poses heightened risk.

What products contain acetaminophen (apap)?

Acetaminophen (APAP) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to acetaminophen (apap)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about acetaminophen (apap)?

Acetaminophen (APAP) has been classified by 8 agencies including FDA, EPA CTX / IARC, EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Acetaminophen (APAP) in the baby app

Look up products containing acetaminophen (apap), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)
  1. FDA: Acetaminophen (APAP) OTC Drug Facts Labeling and Safety Review (2023) — regulatory
  2. ASPCA Animal Poison Control Center: Acetaminophen Toxicity in Pets (2021) — report
  3. Richardson JA: Management of acetaminophen and ibuprofen toxicoses in dogs and cats. Vet Clin North Am Small Anim Pract 30(3):545–555 (2000) — journal

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →